Boston Scientific Q3 2025 slides: sales surge 20.3%, company raises guidance
PositiveFinancial Markets

Boston Scientific has reported an impressive 20.3% surge in sales for Q3 2025, prompting the company to raise its financial guidance for the year. This growth reflects strong demand for its medical devices and positions the company favorably in the competitive healthcare market. Investors and stakeholders are likely to view this positive trend as a sign of robust operational performance and future potential.
— Curated by the World Pulse Now AI Editorial System